Skip to main content
Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc. — Investor Relations & Filings

Ticker · TNYA ISIN · US87990A1060 US Manufacturing
Filings indexed 304 across all filing types
Latest filing 2026-04-16 Annual Report
Country US United States of America
Listing US TNYA

About Tenaya Therapeutics, Inc.

https://www.tenayatherapeutics.com/

Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and delivering potentially curative therapies for heart disease. The company's approach targets the underlying genetic drivers of cardiovascular conditions using its gene therapy platform. Its lead clinical-stage programs are TN-201, a gene therapy for MYBPC3-associated hypertrophic cardiomyopathy (HCM), and TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC). Founded by cardiovascular scientists, Tenaya aims to change the treatment paradigm for individuals with these debilitating conditions.

Recent filings

Filing Released Lang Actions
ARS - Tenaya Therapeutics, Inc. (0001858848) (Filer)
Annual Report
2026-04-16 English
DEF 14A - Tenaya Therapeutics, Inc. (0001858848) (Filer)
Proxy Solicitation & Information Statement
2026-04-16 English
4 - TENAYA THERAPEUTICS, INC. (0001858848) (Filer)
Director's Dealing
2026-02-26 English
4 - TENAYA THERAPEUTICS, INC. (0001858848) (Filer)
Director's Dealing
2026-02-24 English
4 Filing
Director's Dealing
2026-02-17 English
4 Filing
Director's Dealing
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.